Diphenhydramine Injection Shortage

• • Diphenhydramine injection, Fresenius Kabi, 50 mg/mL, 1 mL vial, 25 count, NDC 63323-0664-01
  • Diphenhydramine injection, Hikma, 50 mg/mL, 1 mL vial, 25 count, NDC 00641-0376-25

• • Armas has diphenhydramine injection available.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Hikma did not provide a reason for the shortage.
  • Viatris Kabi has diphenhydramine injection available.

• • Diphenhydramine injection, Armas Pharmaceuticals, 50 mg/mL, 1 mL vial, 5 count, NDC 72485-0101-05
  • Diphenhydramine injection, Armas Pharmaceuticals, 50 mg/mL, 1 mL vial, 25 count, NDC 72485-0101-25
  • Diphenhydramine injection, Fresenius Kabi, 50 mg/mL, 1 mL Simplist syringe, 10 count, NDC 76045-0102-10
  • Diphenhydramine injection, Mylan Institutional (Viatris), 50 mg/mL, 10 mL vial, 10 count, NDC 67457-0124-10

Estimated Resupply Dates

• • Fresenius Kabi has diphenhydramine 50 mg/mL 1 ml vials on back order and the company estimates a release date of late-May 2024.
  • Hikma has diphenhydramine 50 mg/mL 1 mL vials on allocation.